Diversification Rating
4 /10
Expense Ratio Rating
9 /10
Expense Rating
5 /10
Market Score
7 /10
Category Score
5 /10
Market Size
7 /10
$PDN Alternatives
Different Funds
We found 9,859 International Stocks Mid-Cap Value funds. Here they are ordered by FI Score.
- tvrix
- Mutual Fund
- US Stocks
- Large Growth
Guggenheim Directional Allocation Fund Class I
Expenses: 1.11% (Better than 0% of similar funds)
This is a bad choice for a Large Growth US Stocks fund. See why »
- uci
- ETF
- Commodities
- Broad
UBS ETRACS CMCI Total Return ETN
Expenses: 0.55% (Better than 1% of similar funds)
This is a bad choice for a Broad Commodities fund. See why »
- vscox
- Mutual Fund
- US Stocks
- Small Growth
JPMorgan Small Cap Blend Fund Class A
Expenses: 1.24% (Better than 0% of similar funds)
This is a bad choice for a Small Growth US Stocks fund. See why »
- wbsix
- Mutual Fund
- US Stocks
- Small Growth
William Blair Small Cap Growth Fund Class I
Expenses: 1.25% (Better than 0% of similar funds)
This is a bad choice for a Small Growth US Stocks fund. See why »
- wecdx
- Mutual Fund
- US Stocks
- Large Growth
Wells Fargo Endeavor Select Fund - Class Admin
Expenses: 1.00% (Better than 1% of similar funds)
This is a bad choice for a Large Growth US Stocks fund. See why »
- wfopx
- Mutual Fund
- US Stocks
- Large Growth
Wells Fargo Opportunity Fund - Class C
Expenses: 1.96% (Better than 0% of similar funds)
This is a bad choice for a Large Growth US Stocks fund. See why »
- wsidx
- Mutual Fund
- Bond
- High Yield Bond
Wells Fargo Strategic Income Fund - Class Admin
Expenses: 0.75% (Better than 1% of similar funds)
This is a bad choice for a High Yield Bond Bond fund. See why »
- wsmcx
- Mutual Fund
- US Stocks
- Small Growth
Wells Fargo Small Company Growth Fund - Class C
Expenses: 2.06% (Better than 0% of similar funds)
This is a bad choice for a Small Growth US Stocks fund. See why »
- phstx
- Mutual Fund
- Sector Equity
- Healthcare
Putnam Global Health Care Fund Class A
Expenses: 1.09% (Better than 0% of similar funds)
This is a bad choice for a Healthcare Sector Equity fund. See why »